ETON PHARMACEUTICALS

Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product Nitisinone

04 Oct 2023 06:50:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

23 Aug 2023 06:50:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Second Quarter 2023 Financial Results

10 Aug 2023 16:01:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023

01 Aug 2023 16:05:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Receives Complete Response Letter (CRL) for Dehydrated Alcohol Injection

28 Jun 2023 06:50:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports First Quarter 2023 Financial Results

11 May 2023 16:01:01 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Commercial Availability of Betaine Anhydrous for Oral Solution, a Generic Version of Cystadane® (betaine anhydrous for oral solution)

10 May 2023 06:50:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023

03 May 2023 16:05:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Fourth Quarter 2022 Financial Results

16 Mar 2023 16:01:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Acquisition of Rare Disease Product Candidate ET-600

15 Mar 2023 06:50:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Fourth Quarter 2022 Financial Results on Thursday, March 16, 2023

07 Mar 2023 16:05:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces FDA Acceptance of NDA Response for Dehydrated Alcohol Injection

11 Jan 2023 06:50:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Third Quarter 2022 Financial Results

10 Nov 2022 16:05:01 By Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Third Quarter 2022 Financial Results on Thursday, November 10, 2022

02 Nov 2022 16:05:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals to Present at the LD Micro Main Event XV Conference

18 Oct 2022 06:50:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Acquisition of FDA-Approved Rare Disease Product, Betaine Anhydrous for Oral Solution

13 Sep 2022 09:00:01 By Nasdaq GlobeNewswire

Eton Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference

30 Aug 2022 16:05:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Second Quarter 2022 Financial Results

11 Aug 2022 16:01:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Second Quarter 2022 Financial Results on Thursday, August 11, 2022

02 Aug 2022 08:00:02 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces FDA Approval of ZONISADE™ (Zonisamide Oral Suspension)

18 Jul 2022 07:05:00 By Nasdaq GlobeNewswire